news.cision.com

The AGM of Husqvarna AB (publ) was held on April 7, 2022 Due to the ongoing Covid-19 situation, the AGM was conducted pursuant to a so-called mail-in procedure in accordance with Sec. 22 of the Act regarding temporary exceptions to facilitate the holding of annual general meetings (Sw. lagen (2022:121) om tillfälliga undantag för att underlätta genomförandet av bolags- och föreningsstämmor). Shareholders participated in the meeting by voting or submitting questions in advance on the proposals at the AGM. Adoption of the Income Statements and Balance Sheets, dividend and discharge of

Indutrade acquires PMH International AB

Indutrade has signed an agreement to acquire all shares in the Swedish company PMH International AB, www.pmh.se, www.pmh-hallen.se, with annual sales of approximately SEK 140 million.PMH is a specialised technical trading company operating in the market segments lifting and material handling equipment as well as industrial/storage halls. The company’s broad and deep offering in the area of lifting and material handling includes e.g. swing jib cranes, manual chain blocks, electric lever hoists, pneumatic hoists, vacuum lifters, aluminum profile rails and traverses. PMH offers a total

Arise publishes Annual Report 2021

The Annual Report of Arise AB 2021, is now available on our website www.arise.se It is sent by post to shareholders who have notified the Company that they wish to receive a copy. Printed copies of the report can be ordered via info@arise.se. Halmstad, 7 April 2022Arise AB (publ) For further information, please contact:Per-Erik Eriksson, CEO Arise AB, +46 702 409 902Markus Larsson, CFO Arise AB, +46 735 321 776 This information is information that Arise AB is obliged to make public pursuant to the Securities Markets Act. The information was submitted

Prospective investigator-initiated study for 2 years’ follow-up of Episealer® Talus patients initiated

Thu, Apr 07, 2022 15:28 CET

Episurf Medical (Nasdaq: EPIS B) today announces the initiation of a prospective investigator-initiated study with 2 years’ follow-up of 25 Episealer® Talus patients. The study is performed by a team at Royal National Orthopaedic Hospital NHS Trust, Stanmore, United Kingdom, with Mr Karan Malhotra as Principal Investigator. The Royal National Orthopaedic Hospital is the largest orthopaedic hospital in the UK, and regarded as a leader in the field of orthopaedics both in the UK and world-wide. The study will evaluate the clinical performance of the Episealer® Talus implant in patients who

Tongji Hospital selects RayStation

RaySearch Laboratories AB (publ) announces that Mevion China has placed an order for RayStation®* which Mevion China has sold together with Mevion’s HYPERSCAN® proton therapy system to Tongji Hospital in Wuhan in China.RaySearch and Mevion have been collaborating since 2014. Treatment planning for particle treatments (protons/carbon ions/BNCT) is an important focus area for RaySearch and today RayStation has a global market share of more than 50 percent, a position that is further strengthened by the new order. RaySearch has about 70 RayStation customers in China through its own

Everfuel to build heavy-duty hydrogen station in Germany

Thu, Apr 07, 2022 15:27 CET

Herning, Denmark, 7 April, 2022 – Everfuel awarded contract for constructing and commissioning of a heavy-duty hydrogen refuelling station in Wuppertal, Germany. After a European-wide tendering procedure, WSW mobil GmbH has awarded Everfuel GmbH the contract for a hydrogen refuelling station that will serve a fleet of fuel cell buses for public transportation. It is the second contract in Germany for Everfuel GmbH for a hydrogen refuelling station for fuel cell buses since the company was founded at the beginning of 2021 as a wholly owned subsidiary of Everfuel A/S from Denmark. "

Correction: Notice of the Annual General Meeting of Optomed Plc

Thu, Apr 07, 2022 15:15 CET

Optomed Plc Stock Exchange Release 7 April 2022 at 16.15, Helsinki CORRECTION: NOTICE OF THE ANNUAL GENERAL MEETING OF OPTOMED PLC Optomed corrects a mistake that was in the notice of the annual general meeting release announced today 7 April 2022. Due to a technical issue, the agenda stated in the original release did not include agenda point 1, Opening of the meeting. The complete release including the correction is below: Notice is given to the shareholders of Optomed Plc (“Optomed” or the “Company”) of the Annual General Meeting to be held on Tuesday, 10 May 2022 at

Sedana Medical publishes Annual Report 2021

Sedana Medical AB (publ) (SEDANA: FN Stockholm) published its Annual Report 2021.In addition to significant events and financial information of 2021, the Annual Report focuses on the strategic priorities and ambitions to introduce inhaled sedation to intensive care. “In 2021, we delivered the highest turnover in our history and made strong progress on both of our main priorities: to execute an excellent launch of Sedaconda (isoflurane) in Europe and to prepare for the important US market”, said Johannes Doll, CEO of Sedana Medical. The Annual Report is available at www.sedanamedical.

BERGENBIO ASA: NOTICE OF ANNUAL GENERAL MEETING

Bergen, Norway – 7 April 2022: BerGenBio ASA (OSE:BGBIO) will be holding its Annual General Meeting virtually on 28 April 2022 at 10:00 hours (CEST). The notice, power of attorney and proposal from Nomination Committee are attached to this release. The notice will be sent to all registered shareholders and is available on the Company’s website: https://www.bergenbio.com/investors/general-meetings/ All shareholders are encouraged to exercise their shareholder rights, either through advance electronically voting through VPS Investor Services, by using the enclosed proxy form

Pricer updates on the first quarter of 2022

Pricer’s sales for the first quarter of 2022 are expected to amount to around SEK 465 (393) million and operating profit (EBIT) to around SEK -10 (17.3) million.In the quarterly report for the fourth quarter of 2021, Pricer announced that increased prices for electronic components, raw materials, and transportation was the main reason for a lower operating profit compared with the same period last year. The elevated price situation has persisted and, in some cases, increased during the first quarter of 2022, which has had a negative effect on Pricer’s earnings. In addition, negative

As part of SAS FORWARD Plan, SAS defers interest payment on perpetual capital securities

Thu, Apr 07, 2022 14:30 CET

As part of the SAS FORWARD Plan, outlined in the SAS AB (publ) (SAS or the “Company”) press release on the 22 February 2022 in connection with the Q1 results, SAS will defer the interest payments due 25 and 26 April 2022 on its Capital Securities. The deferral of interest payment is made in accordance with the terms and conditions for the respective Capital SecuritiesThis means that SAS defers the SEK 36 m semi-annual interest payment due 25 April 2022 on its outstanding SEK 1,615 bn perpetual capital securities with ISIN SE0014957999 and the SEK 138 m semi-annual interest payment due 26

EMBARGOED UNTIL 00.01 FRIDAY 8 APRIL: Effective arrangements in place at Abertay University, according to independent quality experts

Abertay University has ‘effective arrangements for managing academic standards and the student learning experience’, according to a review conducted by QAA, the UK’s independent higher education quality body. The review commended the University’s achievements in several areas including student partnership and the creation of an inclusive and accessible learning environment.The review was undertaken by a team of six independent reviewers, who were appointed by QAA. The review took place through a Planning Visit in October 2021, followed by a Review Visit in November and December 2021. Its

ShaMaran Publishes Swedish Prospectus in Connection with an Underwritten Rights Issue and Corporate Updates

Thu, Apr 07, 2022 14:30 CET

VANCOUVER, BC, April 7, 2022 /CNW/ - ShaMaran Petroleum Corp. (“ShaMaran” or the “Company”) (SNM: TSX-V and Nasdaq First North Growth Market (Sweden)) is pleased to announce that the board of directors of the Company has prepared a prospectus (the “Prospectus”) in connection with the rights issue of up to approximately USD 30.5 million (290.2 million SEK[1]) (the “Rights Issue”) previously announced in the news release of April 5, 2022. The Prospectus has today been approved and registered by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen) and is available on the

Terveystalo Plc: Resolutions of Annual General Meeting

Thu, Apr 07, 2022 14:30 CET

Terveystalo Plc, Stock Exchange Release 7 April 2022 at 3:30 p.m. EESTThe Annual General Meeting of Terveystalo Plc was held today on 7 April 2022 in Helsinki, Finland. The Annual General Meeting adopted the financial statements for the financial year 2021 and discharged the members of the Board of Directors and the CEO from liability. The Annual General Meeting approved the remuneration report for governing bodies and decided to support the amended remuneration policy for governing bodies which was presented to the Annual General Meeting. Use of the profit shown on the balance sheet

Arise has signed asset management agreement in Finland

Thu, Apr 07, 2022 14:10 CET

Arise AB (publ) (”Arise”) has signed an asset management agreement with BlackRock regarding four wind farms in Finland, with an installed capacity of close to 200 MW. In addition to these four wind farms, which are under construction, Arise already manages one of BlackRock’s commissioned wind farms in Finland and the assignment now totals 219 MW. ”We are very proud that BlackRock choses to continue building upon our long-standing relationship and the assignment is an important step in our geographical expansion”, says Per-Erik Eriksson, CEO, Arise AB. Halmstad, 7 April 2022 ARISE

Enduro Genetics closes first funding round and strengthens team to broadly enable large-scale biological production

Thu, Apr 07, 2022 14:05 CET

Today, the Danish biotech company, Enduro Genetics, announces the closure of its first funding round, led by NOON Ventures. Enduro Genetics is a spinout from the Technical University of Denmark enabling large-scale fermentation. Founded by Peter Rugbjerg and Christian Munck, the company is one of the latest biotech successes evolving from the European life science incubator BioInnovation Institute in Copenhagen. Relying on living organisms, green biological production can be difficult to scale to large markets. This broad challenge constrains the global transition to more

BERGENBIO ASA: BOARD APPROVAL OF 2021 ANNUAL FINANCIAL STATEMENT AND ANNUAL REPORT 2021

Bergen, Norway – 7 April 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announces that the Board of Directors today approved the 2021 Annual Financial Statements prepared in accordance with International Financial Reporting Standards (IFRS). The Annual Report for 2021 and ESEF file are attached to this release and are also available on BerGenBio ASA's website https://www.bergenbio.com/investors/reports/ Contacts: For BerGenBio: Martin Olin CEO, BerGenBio ASA

Notice of Annual General Meeting of Shareholders in Alligo AB (publ) on 11 May 2022

The shareholders in Alligo AB (publ), corporate registration number 559072-1352 (“Alligo” or the “Company”), are hereby convened to the Annual General Meeting of Shareholders at 10:00 on Wednesday, 11 May 2022 at Kapitel 8, Klarabergsviadukten 90, Stockholm. Registration for the meeting will commence at 09:30.REGISTRATION AND NOTIFICATION Shareholders who wish to participate in the Annual General Meeting must · be recorded in the shareholders’ register maintained by Euroclear Sweden AB not later than Tuesday, 3 May 2022, and, · file notice of their intention to participate with

Bittium Launches Next Generation Bittium Tough VoIP Field Phone™ 2 for Tactical Communications

Press release Free for publication on April 7, 2022 at 3.00 p.m. (CEST+1) Bittium Launches Next Generation Bittium Tough VoIP Field Phone™ 2 for Tactical Communications Oulu, Finland, April 7, 2022 – Bittium, leading supplier of tactical and secure communications solutions, complements its tactical communications product portfolio with Bittium Tough VoIP Field Phone™ 2. The Field Phone 2 is a next generation VoIP phone that enables reliable communications in demanding conditions. Field Phone 2 is designed for military use and thanks to its features, accessories, and powering

Notice of the Annual General Meeting of Optomed Plc

Optomed Plc Stock Exchange Release 7 April 2022 at 15.00, Helsinki NOTICE OF THE ANNUAL GENERAL MEETING OF OPTOMED PLC Notice is given to the shareholders of Optomed Plc (“Optomed” or the “Company”) of the Annual General Meeting to be held on Tuesday, 10 May 2022 at 10:00 a.m. (EEST) at Life Science Center Keilaniemi, Keilaranta 16 B, FI-02150 Espoo, Finland. Shareholders of the Company can only participate in the meeting and exercise their shareholders’ rights by voting in advance or through a proxy representative as well as by posing counterproposals and questions in advance.

Resolutions of EAB Group Plc’s Annual General Meeting and the organizing meeting of EAB Group Plc’s Board of Directors on 7 April 2022